Three Artificial Liver Models of Treatment of Acute-on-Chronic Liver Failure
PE, PP+PE and DPMAS+PE three artificial liver treatment modes can effectively improve liver, kidney and coagulation function of ACLF patients. DPMAS+PE demonstrated better ability to remove endotoxin and inflammatory mediators, showed advantages in reducing ACLF patient mortality within 90 days, and had the least impact on electrolyte post-treatment. Therefore, DPMAS+PE can be used as a better choice for clinical treatment.
Authors
- Jia Cai (ORCID: https://orcid.org/0000-0002-9501-7336)
- Renhua Li
- Yanping Xiang (ORCID: https://orcid.org/0000-0002-9477-284X)
- Qian Jiang (ORCID: https://orcid.org/0000-0001-7131-0522)
Institutions
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Therapeutics and Clinical Risk Management
- Published
- 2024-10-01
- DOI
- https://doi.org/10.2147/tcrm.s485620
- Citations
- 6
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 2.22